Furthermore, miR-4429 or silencing SEC62 blocked tumor cell proliferation and facilitated apoptosis, suggesting that miR-4429 and its downstream gene METTL3 are potential targets for gastric cancer prevention and management [124]. This evidence concerns the gene METTL3 and neoplasm.